What is the projected stock price for NCNA

The deep research logic is organized as follows: 

Okay, let's tackle the user's question about the projected stock price for NCNA. First, I need to check the references provided. The user mentioned several sources, including analyst ratings, stock analysis, and recent news about delisting threats and financial agreements.

Starting with the analyst ratings, Reference 6 from MarketBeat shows an average price target of $25.00 based on two analysts. However, Reference 9 from Marketscreener.com mentions a consensus with no average target price, which is conflicting. Also, Reference 3 and 4 talk about a $150 price target from a buy rating, but that seems inconsistent with the other data. I need to clarify which sources are more recent and reliable.

Looking at the delisting threat in References 3 and 4, the stock price dropped below $0.10, which is a critical point. The recent surge mentioned in Reference 4 (50% pre-market) might indicate short-term volatility. The ADS sales agreement in References 5 and 14 could provide some financial stability, but the cash runway is still a concern as per Reference 2.

The technical analysis from Reference 2 shows bearish trends with negative moving averages and low RSI. The market cap is only $19.16M, which is small, making the stock more volatile. The lack of revenue and high cash burn rate are significant negatives.

Putting this together, the analyst consensus is mixed. Some sources suggest a high target like $150, while others have a lower target of $25. The recent news about delisting and the stock's surge might indicate speculative interest, but the fundamentals are weak. The user is asking for the projected stock price, so I need to present the conflicting data and explain the uncertainty.

I should structure the answer by first stating the lack of consensus, then listing the different price targets from various sources, and finally discussing the factors influencing these projections. It's important to highlight the risks like delisting, financial instability, and speculative nature of the stock. Also, mention the technical indicators and market sentiment as they play a role in price movements.

I need to ensure that all citations are correctly referenced and that the answer doesn't fabricate any information. The conclusion should reflect the high uncertainty and advise caution for investors. Using tables to present the price targets and factors will make the answer clearer.

### 🌟 **Conclusion**
**NuCana (NCNA) presents a highly speculative and uncertain outlook**, with conflicting analyst projections and significant risks tied to its financial stability and regulatory compliance. The stock’s projected price targets range from **$1.00 to $150.00**, reflecting extreme volatility and divergent market sentiment. Below is a detailed breakdown of the key factors shaping NCNA’s stock price trajectory.

---

### 📊 **Key Analysis**

#### 1. **Analyst Price Targets**
| Source | Price Target | Upside Potential | Key Notes |
|-----------------------|--------------|-------------------|---------------------------------------------------------------------------|
| **MarketBeat** | $25.00 | +49,700.8% | Based on 2 analysts; average upside from $0.05. |
| **TipRanks** | $150.00 | +298,704.78% | Buy rating with speculative upside; no revenue or profitability. |
| **Marketscreener** | N/A | N/A | No consensus target; mixed analyst activity. |

#### 2. **Market Sentiment & Risks**
- **Delisting Threat**: NCNA’s ADS price fell below $0.10, risking delisting . A hearing request may delay suspension but does not guarantee compliance.
- **Financial Instability**: Negative cash flow, no revenue, and high cash burn rate .
- **Speculative Nature**: Low market cap ($19.16M) and high volatility (50% surge, 16.28% drop) .

#### 3. **Technical Indicators**
| Metric | Value | Implication |
|--------------|------------|---------------------------------------|
| **50DMA** | $0.12 | Bearish trend (vs. current $0.04) |
| **RSI** | 35.67 | Neutral (oversold potential) |
| **MACD** | -0.03 | Negative momentum |

#### 4. **Catalysts for Price Movement**
- **Clinical Data**: Phase 2 results for NUC-7738 in melanoma (Q4 2025) .
- **Regulatory Updates**: FDA guidance on NUC-7738’s pivotal study design .
- **Liquidity Changes**: ADS ratio adjustment (1:5,000) to boost trading price .

---

### 📉 **Why the Wide Price Range?**
- **Optimistic Scenario**: Success in clinical trials and regulatory approvals could drive the stock to $150.00 .
- **Pessimistic Scenario**: Delisting, cash crunch, or failed trials could push the stock below $0.10 .
- **Neutral Scenario**: Stabilization at $25.00 if NCNA secures funding and maintains compliance .

---

### 🚨 **Key Takeaways**
- **High Risk**: NCNA’s stock is highly speculative with no guarantee of upside.
- **Focus on Catalysts**: Monitor clinical data, regulatory updates, and liquidity changes.
- **Diversification**: Consider NCNA as a high-risk, high-reward holding in a diversified portfolio.

---

### 📊 **Final Outlook**
**NCNA’s stock price is a gamble**, with potential upside to $150.00 but significant risks of delisting and financial collapse. Investors should proceed with extreme caution and prioritize diversification.

**Final Rating**: **Speculative Buy** (High risk, uncertain upside).